-
Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria
2026-06-07
Tetramethylrhodamine ethyl ester perchlorate (TMRE) delivers unmatched sensitivity and quantitative insight for live-cell mitochondrial membrane potential assays. By leveraging TMRE’s robust fluorescence and low cytotoxicity, researchers can confidently dissect mitochondrial health, dysfunction, and bioenergetics in complex disease models—enabling translational discovery from mechanism to therapeutic evaluation.
-
Bafilomycin C1 in Cardiotoxicity Screening: Beyond Autophagy
2026-06-06
Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, transforms cardiotoxicity screening in human iPSC-derived models. This article goes beyond standard autophagy assays to reveal new assay strategies and mechanistic insights, grounded in recent advances.
-
Mitomycin C: Antitumor Antibiotic Solutions for Reliable Ass
2026-06-05
This article addresses real-world laboratory challenges in apoptosis signaling and cancer research, highlighting how Mitomycin C (SKU A4452) from APExBIO delivers reproducible, data-driven results. Through scenario-based analysis, it demonstrates the compound’s strengths in protocol optimization, data interpretation, and vendor reliability for cell viability and cytotoxicity workflows.
-
UBE2F-SAG Neddylation of RHEB Drives mTORC1 Activation in Li
2026-06-05
This study identifies RHEB as a direct neddylation substrate of the UBE2F-SAG axis, revealing a mechanism that enhances mTORC1 activity and promotes liver tumorigenesis. The findings highlight the UBE2F-SAG-RHEB pathway as a potential therapeutic target in hepatocellular carcinoma and related metabolic diseases.
-
Necrostatin 2: Optimizing Necroptosis Inhibition Workflows
2026-06-04
Necrostatin 2 (Nec-2) empowers researchers to dissect necroptosis with nanomolar precision, targeting the RIPK2 pathway even when apoptosis is blocked. This guide unpacks experimental strategies, troubleshooting, and actionable insights for advancing programmed necrotic cell death research.
-
Stability-Driven mRNA Assays: EZ Cap™ Firefly Luciferase mRN
2026-06-04
Discover how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure empowers stability-focused research, bridging in vitro and in vivo performance. Uncover novel assay strategies and protocol optimizations that set this mRNA apart from existing bioluminescent reporter tools.
-
Ceftolozane/Tazobactam: Innovations in Treating Resistant Gr
2026-06-03
The reference study provides a comprehensive evaluation of ceftolozane/tazobactam, a novel cephalosporin/β-lactamase inhibitor that addresses multidrug-resistant Gram-negative infections. Its unique pharmacodynamics and spectrum, especially against Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae, mark significant progress in combating antimicrobial resistance in clinical settings.
-
Ademetionine’s Methylation Pathways in Neurological Disorder
2026-06-03
This review analyzes the central role of ademetionine (S-adenosylmethionine, SAMe) in CNS methylation and its clinical potential for neurological disorders. The findings highlight SAMe's broad metabolic functions, its interplay with folate and vitamin B12, and implications for neuropsychiatric treatment strategies.
-
Pulchinenoside B4 Inhibits NLRP3 Inflammasome in Colitis via
2026-06-02
This study identifies Pulchinenoside B4 as a potent suppressor of NLRP3 inflammasome activation in macrophages, mediated by targeting CD1d and dampening the AKT-STAT1-PRDX1-NF-κB axis. The findings highlight a selective anti-inflammatory mechanism with translational potential for ulcerative colitis and provide a molecular framework for future inflammation research.
-
TSPAN18 Stabilizes STIM1 to Drive Bone Metastasis in Prostat
2026-06-02
Zhou et al. uncover a novel mechanism where TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, promoting calcium signaling and bone metastasis in prostate cancer. These findings highlight TSPAN18 as a promising target for disrupting metastatic progression in hormone-responsive cancer research.
-
Topotecan HCl for Antitumor Workflows: Mechanism to Optimiza
2026-06-01
Topotecan HCl enables robust, reproducible antitumor assays by leveraging topoisomerase 1 inhibition and quantifiable DNA damage. Discover data-driven workflow enhancements, troubleshooting strategies, and reference study insights that elevate research in lung and prostate cancer models.
-
Syringin Natural Product: Applied Protocols and RCC Research
2026-06-01
The Syringin natural product empowers researchers to precisely modulate signaling pathways and apoptosis in advanced RCC models. This article translates bench-proven workflows and troubleshooting strategies, enabling robust bioactive compound screening and greater reproducibility in natural product research.
-
Erastin (SKU B1524): Reliable Ferroptosis Inducer for Cancer
2026-05-31
This article delivers scenario-driven guidance for laboratory scientists investigating ferroptosis and oxidative stress with Erastin (SKU B1524). Drawing on validated protocols, comparative insights, and recent literature, it demonstrates how Erastin ensures reproducibility and sensitivity in cancer biology research workflows.
-
KR-12 Human Antimicrobial Peptide: Protocols and Applied Ins
2026-05-30
KR-12 (human) TFA is the minimal, potent LL-37 fragment with targeted antimicrobial, anti-biofilm, and immunomodulatory activities. This guide details protocol-ready workflows, troubleshooting solutions, and translational insights—empowering researchers to fully leverage KR-12’s unique properties against multidrug-resistant pathogens and inflammatory models.
-
Metronidazole as an OAT3 Inhibitor: Precision in Drug-Drug I
2026-05-29
Explore the multifaceted role of Metronidazole as a potent OAT3 inhibitor and nitroimidazole antibiotic in drug-drug interaction research. This article offers a deeper comparative analysis, mechanistic insights, and advanced assay guidance beyond existing protocols.
444 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page